Analgesics, OpioidComorbidityQualitative ResearchRegistriesAttention Deficit Disorder with HyperactivityHospitalizationAlcoholismBenzodiazepinesCentral Nervous System StimulantsSwedenSubstance-Related DisordersSubstance Withdrawal SyndromePatient Acceptance of Health CareAmphetaminesDrug Packaging
Dr. Franck studies the effects of prescription medications, especially psychostimulants and antidepressants, on mental health conditions such as ADHD, substance use disorders, and borderline personality disorder. He is particularly interested in understanding how these medications interact with patients’ histories, such as prior substance use or mental health issues. His research also delves into genetic factors influencing the relationship between ADHD and substance use, providing insights that help tailor treatments for individuals facing multiple challenges in their mental health journey.
Key findings
In a study of over 132,000 adults, those with a history of stimulant use disorder had a 21% lower rate of hospitalizations after starting treatment with prescription stimulants or atomoxetine.
Among 3,770 adults with a history of psychosis, the risk of psychotic events remained stable at 0.95 after starting treatment with psychostimulants or atomoxetine.
Approximately 20% of individuals with substance use disorders also had attention-deficit/hyperactivity disorder (ADHD), with genetic scores linking ADHD to higher chances of heroin use (0.7% increase) and opioid use disorder symptoms (0.6% increase).
Adults with both ADHD and substance use disorders who received stimulant treatment were 2.4 times more likely to remain in treatment and showed a 30% reduction in ADHD symptoms compared to those who did not receive treatment.
Patients with severe alcohol use disorder who were prescribed relapse-prevention medications saw a 39% reduction in hospitalization risk, highlighting the importance of appropriate medication combinations.
Frequently asked questions
Does Dr. Franck study ADHD?
Yes, Dr. Franck studies ADHD and its interaction with substance use disorders, focusing on effective treatment strategies.
What treatments has Dr. Franck researched?
He has researched various medications including psychostimulants, atomoxetine, antidepressants, and relapse-prevention medications for treating substance use disorders.
Is Dr. Franck's work relevant to patients with borderline personality disorder?
Yes, his research on psychotherapy for borderline personality disorder shows it can improve interpersonal relationships, particularly for those with co-occurring mental health issues.
How does Dr. Franck's research help patients with substance use disorders?
His findings provide critical insights into treatment options and outcomes, showing how managing conditions like ADHD can lead to better results for those with substance use disorders.
What is the significance of Dr. Franck's genetic studies?
His genetic studies highlight shared risk factors for ADHD and substance use disorders, which could improve understanding and treatment for individuals facing both challenges.
Publications in plain English
Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder.
2026
European archives of psychiatry and clinical neuroscience
Bach P, Franck J, Hällgren J, Widing H, Gissler M +1 more
Plain English This study looked at how different medications help people with severe alcohol use disorder (AUD) avoid being hospitalized for alcohol-related issues. Researchers analyzed data from over 14,000 people and found that relapse-preventive medications significantly reduced the risk of hospitalization by 39% (hazard ratio of 0.61), while antidepressants alone did not show a benefit. Using both types of medication together was also helpful, reducing hospitalization risk by 37% (hazard ratio of 0.63).
Who this helps: Patients suffering from severe alcohol use disorder.
Predictors of outpatient treatment engagement following a visit to a specialized emergency department for substance use: A cohort study using high-resolution electronic health records.
2026
Addiction (Abingdon, England)
Romero D, Kåberg M, Berman AH, Carlbring P, Franck J +1 more
Plain English This study examined how well patients engage in ongoing treatment for substance use disorders after visiting a specialized emergency department in Stockholm. It found that 33.2% of patients returned for outpatient treatment, while nearly half (49.9%) did not engage in any follow-up care. Factors such as prior visits to needle and syringe programs increased the likelihood of seeking follow-up treatment, while being admitted by police lowered it. This is important because better understanding these patterns can help improve post-emergency care and support for individuals struggling with substance use issues.
Who this helps: This helps patients with substance use disorders, particularly those using emergency department services.
Treatment modifiers of interpersonal functioning in psychotherapy for people with borderline personality disorder: Systematic review with meta-analyses of individual participant data.
2026
Clinical psychology review
Pereira Ribeiro J, Stoffers-Winterling J, Jørgensen MS, Juul S, Matbouriahi M +23 more
Plain English This study looked at how effective psychotherapy is for people with borderline personality disorder (BPD) and found that it can improve interpersonal relationships. Researchers examined data from 32 clinical trials involving 2,762 participants; they discovered that those with co-occurring anxiety disorders or multiple mental health issues might benefit more from therapy, although these findings were not statistically strong. This is important because it shows that having other mental health challenges does not automatically mean therapy won't work for someone with BPD.
Who this helps: Patients with borderline personality disorder and their therapists.
Polygenic risk scores reveal genetic underpinnings of comorbidity between substance use disorders and ADHD.
2026
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Horstman LI, Koller D, Cabana-Domínguez J, Llonga N, Icick R +18 more
Plain English This study examined whether there are shared genetic factors between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders (SUD), finding that about 20% of people with SUD also have ADHD. Researchers analyzed data from 1,513 individuals and discovered that certain genetic scores linked ADHD to higher chances of heroin use and opioid use disorder symptoms, with increases of 0.7% and 0.6%, respectively. Understanding this genetic connection can help in developing better treatments for those struggling with both conditions.
Who this helps: This helps patients with ADHD and substance use disorders, as well as their doctors.
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study.
2026
Translational psychiatry
Bach P, Franck J, Hällgren J, Widing H, Gissler M +1 more
Plain English This study looked at whether taking psychostimulants (like ADHD medications) or atomoxetine increases the risk of psychosis in adults who previously experienced psychosis. Researchers analyzed data from 3,770 individuals who had a history of psychosis and started these treatments between 2008 and 2021. They found that the risk of psychotic events did not increase after starting these medications; the rate was actually 0.95, meaning it was about the same as before treatment.
Who this helps: This benefits patients with a history of psychosis and their doctors when considering treatment options.
Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study.
2026
The Lancet regional health. Europe
Bach P, Franck J, Hällgren J, Widing H, Gissler M +1 more
Plain English This study looked at whether taking prescription stimulants or atomoxetine (a non-stimulant) increases the chances of being hospitalized for issues related to stimulant use in adults, both with and without a history of stimulant use disorder (SUD). Researchers found that, out of over 132,000 adults, those with a history of SUD had a 21% lower rate of hospitalizations after starting treatment, while those without SUD saw an 16% decrease. This is important because it suggests that prescribing these medications does not lead to more hospital visits for stimulant-related problems, providing reassurance on their safety.
Who this helps: This information benefits doctors and patients considering treatment options for attention-related disorders.
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS).
2026
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Brynte C, Schellekens A, Konstenius M, Begeman AHA, Crunelle CL +16 more
Plain English This study looked at how treating attention deficit/hyperactivity disorder (ADHD) in adults with substance use disorder (SUD) affects their treatment success. Researchers found that patients who received stimulant treatment for ADHD were 2.4 times more likely to stay in treatment, 2.6 times more likely to see a significant improvement in their ADHD symptoms, and reported 76% fewer heavy drinking days compared to those who didn't receive such treatment. These findings highlight the importance of addressing ADHD when treating individuals with SUD to improve their recovery outcomes.
Who this helps: This helps patients with both ADHD and substance use disorder, as well as their healthcare providers.
Genetic liability for anxiety and treatment response to the monoamine stabilizer OSU6162 in alcohol dependence: a retrospective secondary analysis.
2025
Pharmacological reports : PR
Hong MG, Khemiri L, Guterstam J, Franck J, Jayaram-Lindström N +1 more
Plain English This study looked at how genetic factors connected to anxiety might affect people's response to a treatment called OSU6162, which helps reduce cravings for alcohol. The researchers found that patients with a higher genetic risk for anxiety who received OSU6162 drank fewer alcoholic beverages and had fewer heavy drinking days compared to those who did not receive the treatment. This matters because understanding how genetics influences treatment can lead to more personalized and effective therapies for people dealing with alcohol dependence and anxiety.
Who this helps: This helps patients with alcohol dependence and anxiety.
Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register Study.
2025
Acta psychiatrica Scandinavica
Bach P, Franck J, Hällgren J, Widing H, Gissler M +1 more
Plain English This study looked at how effective certain medications are in reducing hospitalizations related to alcohol use disorder (AUD). Researchers analyzed data from nearly 94,000 people diagnosed with AUD between 2009 and 2019 in Sweden. They found that using medications like naltrexone and disulfiram significantly lowered the risk of alcohol-related hospitalizations, with reductions up to 43% for those using a combination of treatments. This matters because many people with AUD currently don’t receive these medications, so making them more available could significantly improve health outcomes.
Who this helps: Patients with alcohol use disorder.
Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial.
2025
The Lancet regional health. Europe
Söderpalm B, Lidö H, Franck J, Håkansson A, Lindqvist D +6 more
Plain English This study looked at the effects of two medications, varenicline and bupropion, on people with alcohol use disorder (AUD). It found that combining the two drugs significantly reduced heavy drinking days and alcohol levels in the blood compared to a placebo, with participants taking the combination reporting a 31% decrease in heavy drinking days. Additionally, using both medications together helped reduce nausea, a common side effect of varenicline alone.
Who this helps: This research is beneficial for patients struggling with alcohol use disorder and healthcare providers looking for effective treatment options.
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD).
2025
The International journal of social psychiatry
Begeman AH, Schellekens A, van den Brink W, Barta C, Brynte C +18 more
Plain English This study looked at how religiousness relates to the severity of substance use disorder (SUD) and attention deficit/hyperactivity disorder (ADHD) in people who have both conditions. Researchers found that higher levels of religiousness were linked to less severe ADHD symptoms, while stronger self-control was associated with lower severity of both ADHD and SUD symptoms. However, religiousness did not have a direct effect on SUD severity.
Who this helps: This research benefits patients struggling with ADHD and SUD, offering insights into how religious beliefs may support managing their ADHD.
Serum C-reactive protein typically increases at 24 hours postoperatively and then tends to decrease in a majority of dogs following uncomplicated digestive surgery.
2025
Journal of the American Veterinary Medical Association
Le Baut M, Boullenger J, Sériot P, Griffeuille E, Dunié-Mérigot A +2 more
Plain English This study looked at how a specific protein (C-reactive protein or CRP) in dogs changes after they have uncomplicated digestive surgery. Researchers found that CRP levels jumped to a median of 175.6 mg/L 24 hours after surgery and then dropped significantly within just a couple of days, with most dogs (81.5%) showing this pattern. Understanding these changes is important because it helps veterinarians monitor recovery and identify potential complications early.
Who this helps: This helps veterinarians caring for dogs after surgery.
Not primed to agree? Short or no effect of rhythmic priming on typical adults processing number agreement.
2025
Frontiers in psychology
György D, Saddy D, Kotz SA, Franck J
Plain English This study looked at how listening to rhythmic music affects people's ability to understand sentence structures. Researchers found that any improvement from rhythmic music was very small and disappeared quickly; in some cases, it didn’t help at all. For instance, there was a noticeable effect after the first sentence only in one of the three experiments. This is important because it shows that rhythmic music might not significantly help typical adults when processing language, highlighting the complexity of how we understand sentences.
Who this helps: This helps researchers studying language processing and cognitive functions.
Are feature assignment errors due to attraction? The case of Bulgarian numeral phrase.
2025
Frontiers in psychology
Khristov D, Stateva P, Franck J, György D, Stepanov A
Plain English This study looked at how people speaking Bulgarian sometimes make mistakes when using numbers and modifiers, like saying "five rusty old windows," by incorrectly changing the form of the final noun. Researchers found that these errors were influenced more by how close the words were in a sentence rather than their grammatical structure. This matters because it helps us understand how our brains handle language and highlights differences in how we make agreement mistakes compared to other types of language errors.
Who this helps: This helps linguists and language teachers understand language processing better.
Plain English Researchers studied the experiences of people who have used benzodiazepines, a type of medication for anxiety and sleep issues, for a long time and became addicted. They found that many users did not see benzodiazepines as a problem when they started taking them, and there was little discussion about the risks involved. Additionally, patients often had limited communication with their doctors, which allowed their addiction to develop without adequate oversight until they faced the need to stop using the drugs.
Who this helps: This research benefits patients struggling with benzodiazepine addiction and healthcare providers by highlighting the need for better communication about risks and support in reducing medication use.
A national cohort study of long-term opioid prescription and sociodemographic and health care-related risk factors.
2025
Communications medicine
Krüger C, Franck J, Widing H, Hällgren J, Gissler M +1 more
Plain English This study looked at how many people become long-term users of opioids after being prescribed them for the first time in Sweden between 2016 and 2020. Among 754,982 people who hadn't used opioids before, 8.1% started using them long-term, with those treated in primary care being three times more likely to continue using them for over a year compared to others. Understanding these patterns can help doctors manage prescriptions better and reduce the risks of addiction.
Who this helps: This helps patients and doctors in managing pain treatment safely.
Treatment Moderators of Symptom Severity in Psychotherapy for People with Borderline Personality Disorder: Systematic Review with Meta-Analyses of Individual Participant Data.
2025
Psychotherapy and psychosomatics
Pereira Ribeiro J, Stoffers-Winterling J, Jørgensen MS, Juul S, Matbouriahi M +29 more
Plain English This study looked at how different personal characteristics affect the success of psychotherapy for people with borderline personality disorder (BPD). It found that psychotherapy reduced BPD symptoms significantly, with a reduction score of -0.25 compared to standard treatments. However, people with depression or a history of sexual trauma saw less improvement, while those with anxiety or alcohol use disorders responded better to therapy, highlighting the importance of considering these factors in treatment planning.
Who this helps: This helps patients with borderline personality disorder and mental health professionals involved in their care.
Improved opioid prescribing in primary care: protocol for a cluster randomised pragmatic trial.
2025
BMJ open
Krüger C, Franck J, Hällgren J, Af Winklerfelt Hammarberg S, Norman C +2 more
Plain English This study looked at how to improve the way doctors prescribe opioids, which are important for managing pain but can also lead to addiction. Researchers tested an educational program in 24 healthcare centers in Stockholm to see if it would lead to safer prescribing practices over 12 months. They found that this program, which included seminars and feedback, would help doctors better align their prescriptions with guidelines, which is crucial for patient safety.
Who this helps: This helps patients who rely on pain management and need safer prescribing practices.
Risk of substance use disorders in the adult children of parents with severe alcohol use disorder: a nationwide cohort study.
2025
BMC public health
Kane K, Westman J, Franck J, Gissler M
Plain English This study looked at how being the child of a parent with severe alcohol use disorder (AUD) affects the likelihood of developing substance use disorders (SUDs) in adulthood. Researchers found that adult children of parents with severe AUD had a significantly higher risk of developing various SUDs, with risks more than twice as high after adjusting for other factors. Specifically, risks for disorders related to stimulants, volatile solvents, and opioids were notably elevated.
Who this helps: This information benefits families impacted by alcohol use disorder and health professionals working to support them.
New Insights into the Anti-Oomycete Mechanisms of a Leaf Extract fromAgainst.
2024
Phytopathology
Porsche FM, Franck J, Schmitt A
Plain English Researchers studied a leaf extract from licorice to see how effective it is against cucumber downy mildew, a disease that causes major losses in cucumber farming. They found that the extract significantly reduced the infestation rates by between 73% and 96% in two different types of cucumber plants. The extract works by stopping the disease at its early stages, making it a promising alternative to conventional pesticides.
Who this helps: This benefits cucumber farmers looking for safer and effective ways to protect their crops.
The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject Study.
2024
European addiction research
Brynte C, Konstenius M, Khemiri L, Bäcker A, Guterstam J +3 more
Plain English This study looked at how a medication called OROS-methylphenidate (MPH) affects thinking skills in people with both ADHD and amphetamine use disorder compared to those with just ADHD. It found that people with both conditions had worse cognitive abilities and more severe ADHD symptoms. However, while a higher dose of the medication showed some potential for improving these skills in the dual diagnosis group, the results were inconclusive due to issues with the study design.
Who this helps: Patients with ADHD and substance use disorders benefit from improved understanding of treatment effects.
From alcohol detoxification to treatment: A qualitative interview study on perceived barriers and assessed potential of mHealth among individuals postdetoxification.
2024
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
Romero D, Rozental A, Carlbring P, Johansson M, Franck J +2 more
Plain English This study looked at why people who have completed alcohol detoxification often do not continue to get treatment afterward. The researchers interviewed 23 individuals who had been to detox clinics, discovering that they faced significant barriers, such as differences between treatment options and personal needs, as well as practical challenges. Participants also expressed that mobile health (mHealth) tools could effectively support their recovery by increasing self-awareness and connecting them with others, suggesting a potential way to encourage continued treatment.
Who this helps: This benefits patients recovering from alcohol use disorders and healthcare providers seeking effective follow-up support solutions.
Risk of severe mood and anxiety disorders in the adult children of parents with alcohol use disorder: a nationwide cohort study.
2024
Journal of epidemiology and community health
Kane K, Westman J, Franck J, Gissler M
Plain English This study looked at the mental health of adult children whose parents had problems with alcohol. It found that these adults are more likely to experience mood disorders and anxiety disorders—over twice as likely for mood disorders (2.32 times) and about 2.66 times for anxiety disorders—compared to those whose parents did not have alcohol issues. This matters because it highlights the need for targeted mental health support for people who grew up in homes affected by parental alcohol use.
Who this helps: This helps patients who grew up with parents struggling with alcohol addiction.
Computation of Overhauser dynamic nuclear polarization processes reveals fundamental correlation between water dynamics, structure, and solvent restructuring entropy.
2024
Physical chemistry chemical physics : PCCP
Robinson Brown DC, Webber TR, Casey TM, Franck J, Shell MS +1 more
Plain English This study looked at how water behaves near surfaces at a very small scale, which is important for understanding various water-related properties. Researchers used a special technique called Overhauser dynamic nuclear polarization (ODNP) to measure the movement and structure of water near a specific probe, finding that the dynamics of water closely relate to its structural properties and heat behavior. They discovered that as the concentration of glycerol in water increased, different water behaviors were observed, indicating that variations in water dynamics can reflect important changes in its properties.
Who this helps: This research benefits scientists and researchers working on molecular interactions and hydration in biological systems.
Excess mortality among people in homelessness with substance use disorders: a Swedish cohort study.
2024
Journal of epidemiology and community health
Gaber SN, Franck J, Widing H, Hällgren J, Mattsson E +1 more
Plain English This study looked at the death rates of people dealing with substance use disorders (SUDs) in Sweden, focusing on those who are homeless compared to those in stable housing. It found that homeless individuals with SUDs are 13.6 times more likely to die than the general population and 3.7 times more likely to die compared to those with stable housing. This highlights the urgent need for targeted support and health interventions for homeless individuals with substance use issues.
Who this helps: This helps homeless individuals with substance use disorders and the healthcare providers working to support them.
Plain English This study explored how people addicted to benzodiazepines realize they need help to quit. It interviewed 19 adults in treatment, revealing that most participants recognized their addiction as harmful, motivating them to seek support when they felt overwhelmed by negative effects in their lives. Many described a turning point where their use became uncontrollable, leading to worsening withdrawal symptoms and dysfunctional daily life, pushing them to pursue treatment.
Who this helps: This benefits patients struggling with benzodiazepine addiction and healthcare providers working to support their recovery.
Plain English This study looked at how treatment affects individuals struggling with the problematic use of prescription painkillers and anxiety medications over time. It involved 405 patients who had been using these drugs for an average of 11 years before they sought help. The researchers found that a significant number of these patients were prescribed their medications by doctors, even though many also struggled with mental health issues like anxiety and depression.
Who this helps: This research benefits patients in addiction treatment, healthcare providers, and mental health professionals.
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS).
2024
The Journal of clinical psychiatry
Brynte C, Schellekens A, Barta C, Begeman AHA, Crunelle CL +21 more
Plain English This study looked at how patients with both substance use disorders (SUD) and attention-deficit/hyperactivity disorder (ADHD) are treated. Out of 578 patients, about two-thirds (62.8%) received some form of ADHD treatment, with 54% getting medication, 34% receiving therapy, and 25% receiving both. The study found that the location of treatment had a bigger impact on whether patients got ADHD treatment than individual patient differences, highlighting that many patients are not getting optimal care.
Who this helps: This helps patients with both SUD and ADHD, ensuring they receive better treatment options.
Plain English This study looked at how effective and safe diazepam is for treating alcohol withdrawal syndrome in 100 men. It found that patients with certain genetic markers were more likely to experience side effects from diazepam and did not respond as well to the treatment. Specifically, those with specific genetic variations showed a significant increase in adverse reactions, meaning that testing for these genes could help doctors choose better treatments for patients.
Who this helps: This helps patients undergoing treatment for alcohol withdrawal and their doctors.
Container Closure Integrity of Vial Primary Packaging Systems under Frozen Storage Conditions: A Case Study.
2023
PDA journal of pharmaceutical science and technology
Oni YO, Franck J, Evans C, Paniagua D, Kulshrestha A +1 more
Plain English This study looked at how well different types of vials keep drugs sealed when stored in extremely cold conditions, specifically at -80°C. Researchers found that the rubber stoppers used in glass vials and plastic vials could lose their ability to seal properly at these low temperatures, which raises concerns about whether the medicines inside remain safe and effective. This is important because many modern treatments, like vaccines and cell therapies, need to be stored frozen to work correctly.
Who this helps: Patients receiving frozen medical treatments.
Alcohol as a risk factor for mortality in liver transplant patients in Sweden.
2023
Scandinavian journal of gastroenterology
Castedal M, Schult A, Kotopouli MI, Bottai M, Franck J +3 more
Plain English This study looked at how alcohol consumption affects the survival of liver transplant patients in Sweden. Researchers found that patients with alcohol-related liver disease (24 patients) had a much higher risk of dying after their transplant (4 times more likely) and losing their transplanted liver compared to other patients (like those with hepatitis C or tumors). However, the amount of alcohol they drank before or after the transplant did not impact their survival or graft success.
Who this helps: This research helps doctors understand the risks associated with alcohol use in liver transplant patients, particularly those with alcohol-related liver disease.
Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry.
2023
PDA journal of pharmaceutical science and technology
Breckenridge L, Oni Y, Evans C, Franck J, Wood S +3 more
Plain English This study looked at how much harmful metal can leak from a specific type of glass vial used to package medicines. Researchers found that the amount of these metals leached into solutions used for drug formulation was so low that it does not pose any risk to patient safety. This matters because it ensures that the packaging of medicines meets safety standards and protects patients from potential toxins.
Who this helps: Patients and pharmaceutical companies.
Meta-analysis of pharmacogenetic clinical decision support systems for the treatment of major depressive disorder.
2023
The pharmacogenomics journal
Skryabin V, Rozochkin I, Zastrozhin M, Lauschke V, Franck J +2 more
Plain English This study analyzed various research papers to see if using genetic information to guide the dosing of antidepressants works better than the usual method of just guessing the right dose. The findings showed that patients whose treatment was based on their genetics had better outcomes, with a significant increase in response and remission rates after eight and twelve weeks, compared to those who received standard treatment. Importantly, this approach did not lead to more adverse drug reactions.
Who this helps: This helps patients with major depressive disorder by potentially improving their treatment outcomes.
Finding Hierarchical Structure in Binary Sequences: Evidence from Lindenmayer Grammar Learning.
2023
Cognitive science
Schmid S, Saddy D, Franck J
Plain English This study looked at how people understand complex patterns in sequences made of two choices (like 0s and 1s). Researchers used a sequence based on the Fibonacci pattern and found that participants were good at predicting what would come next, showing they understood deeper rules rather than just simple patterns. Specifically, the results indicated that participants anticipated sequences based on a hierarchy, not just surface-level statistics, which suggests they can process more intricate structures.
Who this helps: This benefits researchers studying how people learn patterns and potentially impacts educational methods for teaching complex concepts.
Skryabin VY, Martinotti G, Franck J, Zastrozhin MS
Plain English This paper reviews a condition called acute alcoholic hallucinosis, which mainly involves hearing things that aren’t there, along with other symptoms, often appearing when someone stops drinking alcohol. The study highlights that this condition is the second most common type of alcohol-related mental illness after alcohol delirium, indicating that a significant number of individuals undergoing alcohol withdrawal may experience these hallucinations. Understanding this disorder better can improve how doctors treat patients experiencing these symptoms.
Who this helps: This helps patients recovering from alcohol dependence and their doctors.
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers.
2023
Addiction (Abingdon, England)
Jangard S, Jayaram-Lindström N, Isacsson NH, Matheson GJ, Plavén-Sigray P +4 more
Plain English This study looked at whether the availability of a specific brain receptor, called the D2 receptor, could predict future alcohol use in social drinkers over a follow-up period of 8 to 16 years. Researchers found no significant link between D2 receptor availability and later alcohol use or most related factors, although they did notice a slight connection where lower D2 receptor levels were related to higher impulsivity. This matters because it suggests that the D2 receptor might not be a strong indicator of developing issues with alcohol use.
Who this helps: This helps researchers and healthcare providers understand potential risk factors for alcohol use disorder.
Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorder.
2023
BMC psychiatry
Brynte C, Khemiri L, Stenström H, Konstenius M, Lindström NJ +1 more
Plain English This study looked at how impulsivity affects individuals who have both amphetamine use disorder and attention deficit-hyperactivity disorder (ADHD). Researchers found that participants with both conditions showed higher levels of impulsive behavior and made more impulsive choices compared to those with just ADHD or healthy controls. Specifically, the group with both disorders had significantly more issues with motor control and attention, indicating a greater need for focused treatments for these patients.
Who this helps: This research benefits patients with both amphetamine use disorder and ADHD, as well as their doctors seeking better treatment options.
Stopper Movement and Headspace (Air Bubble Size) Limitations for 2.25 mL Prefilled Syringe.
2023
PDA journal of pharmaceutical science and technology
Evans C, Oni Y, Paniagua D, Franck J, Dahlheim C +1 more
Plain English This study examined how the size of the air bubble in a prefilled syringe affects the movement of the plunger stopper, which is crucial for protecting the syringe’s contents from contamination. Researchers found that a maximum air bubble size of 9.0 mm can still maintain the integrity of the syringe's seal when transported at altitudes up to 17,000 feet. This is important because it ensures that medications in prefilled syringes remain safe and effective even during high-altitude transport.
Who this helps: This helps patients who rely on medications delivered in prefilled syringes.
Systematic compositional analysis of exosomal extracellular vesicles produced by cells undergoing apoptosis, necroptosis and ferroptosis.
2023
Journal of extracellular vesicles
Cappe B, Vadi M, Sack E, Wacheul L, Verstraeten B +8 more
Plain English This study looked at tiny particles called extracellular vesicles (EVs) that are released by cells, particularly when they are dying. Researchers found that EVs produced during different types of cell death contained more proteins than those made under normal conditions. Specifically, the vesicles from necroptosis and apoptosis carried proteins related to making new ribosomes, while those from ferroptosis did not, suggesting that different types of cell death affect the composition of these vesicles in unique ways.
Who this helps: This helps researchers and doctors better understand cell death and its implications for diseases like cancer.
The Hypothesis of Subliminal Cue Reactivity in Addiction Revisited: An fMRI Study.
2022
European addiction research
Guterstam J, Jayaram-Lindström N, Berrebi J, Petrovic P, Ingvar M +2 more
Plain English This study looked at whether people with severe amphetamine addiction react in their brains to hidden images of drugs, even if they don't consciously see them. Researchers used brain scans (fMRI) on 24 amphetamine users and 25 healthy people, but found no significant differences in brain activity between the two groups when they were shown subliminal drug-related images. This suggests that the idea of unconscious responses to drug cues in addiction might not be as strong as previously thought.
Who this helps: This research benefits clinicians and researchers studying addiction by providing clearer insights into how the brain reacts to drug-related cues.
Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity.
2022
Basic & clinical pharmacology & toxicology
Arvidsson M, Franck J, Ackehed G, Pettersson Bergstrand M, Ekström L +2 more
Plain English This study investigated how different doses of methylphenidate (MPH), a medication often used to treat ADHD, affect plasma concentrations in adults who also have substance use disorders. Researchers looked at 28 patients taking daily doses ranging from 30 to 600 mg and found that the concentration of the active form, d-MPH, varied dramatically by up to 25 times among different individuals. The results are important because they show that the presence of a less active form, l-MPH, can affect how physicians gauge a patient’s response to the medication, especially in those with lower enzyme activity that breaks down the drug.
Who this helps: This helps patients with ADHD and substance use disorders, along with their doctors, by improving medication dosing and monitoring.
Substance Use, Hospitalizations, and Co-Occurring Disorders among Patients Transferred from a Needle Exchange Program to Opioid Maintenance Treatment.
2022
International journal of environmental research and public health
Bråbäck M, Brantefors A, Franck J, Brådvik L, Isendahl P +3 more
Plain English This study looked at 71 patients who were moved from a needle exchange program to treatment for opioid addiction. It found that 65% of these patients had to go to the hospital at least once for a psychiatric issue, and nearly three-quarters were diagnosed with a mental health disorder besides their opioid use issue after follow-up. These findings emphasize the need for better mental health care and careful management of sedative use when treating opioid addiction.
Who this helps: This helps patients with opioid use disorders and their healthcare providers.
Initiation of Opioid Prescription and Risk of Suicidal Behavior Among Youth and Young Adults.
2022
Pediatrics
Fine KL, Rickert ME, O'Reilly LM, Sujan AC, Boersma K +6 more
Plain English This study looked at the relationship between starting opioid prescriptions and suicidal behavior among young people in Sweden. It found that young individuals who began using opioids had over twice the risk of suicidal behavior compared to those who did not use opioids. Specifically, 2.2% of those on opioids attempted or committed suicide within five years, compared to 1.9% of those taking nonsteroidal anti-inflammatory drugs (NSAIDs). This research helps to understand the risks involved with prescribing opioids and suggests that while there is an increased risk, it may not be a major concern compared to other factors.
Who this helps: This benefits doctors and healthcare providers in making informed decisions about pain management for young patients.
Prevalence and comorbidity of psychiatric disorders among treatment-seeking elite athletes and high-performance coaches.
2022
BMJ open sport & exercise medicine
Åkesdotter C, Kenttä G, Eloranta S, Håkansson A, Franck J
Plain English This study looked at the mental health issues among elite athletes and high-performance coaches seeking help at clinics in Sweden. It found that 69% of athletes and 91% of coaches had anxiety disorders, with stress-related disorders affecting 72% of coaches and 25% of athletes. These findings highlight the significant mental health challenges faced by individuals in high-pressure sports environments, especially since a quarter of athletes and a considerable number of coaches also deal with eating and substance use disorders.
Who this helps: This research helps patients, coaches, and sports organizations understand the mental health needs of athletes and high-performance coaches.
Mortality in adult children of parents with alcohol use disorder: a nationwide register study.
2022
European journal of epidemiology
Westman J, Jayaram-Lindström N, Kane K, Franck J, Gissler M
Plain English This study looked at the impact of alcohol use disorder in parents on the mortality rates of their adult children in Sweden. It found that adult children of parents with alcohol issues are significantly more likely to die prematurely, with a mortality risk 76% higher overall (HR 1.76). Specifically, they are more at risk of dying from drug-related causes (3.08 times more likely), suicide (2.16 times), and accidents (2.00 times). This is important because it highlights the severe long-term effects that parental alcohol problems can have on their children's lives.
Who this helps: Parents with alcohol use disorder, their children, and healthcare providers working with these families.
Gender specific early treatment for women with alcohol addiction (EWA): Impact on work related outcomes. A 25-year registry follow-up of a randomized controlled trial (RCT).
2022
Drug and alcohol dependence
Berge LI, Gjestad R, Franck J, Javaras KN, Greenfield S +1 more
Plain English This study looked at a specialized treatment program for women with alcohol addiction, called Early treatment for Women with Alcohol Addiction (EWA), and its effects on work-related outcomes over 25 years. The researchers found that women who went through the EWA program had a slower increase in sickness leave compared to those who received standard treatment, and they experienced a greater increase in income within the first eight years after treatment. This matters because it shows that gender-specific treatment can lead to better long-term job-related results for women struggling with alcohol addiction.
Who this helps: This helps women with alcohol addiction and their employers.
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
2022
BMC psychiatry
Brynte C, Aeschlimann M, Barta C, Begeman AHA, Bäcker A +31 more
Plain English This study looked at adults with substance use disorders (SUD) who also have attention deficit hyperactivity disorder (ADHD). It involved 578 patients from nine countries, finding that many had never received treatment for their ADHD and that the most common substances misused were alcohol (54.2%) and stimulants (43.6%). Understanding how these two conditions interact and what treatments work best is important for improving care and outcomes for these patients.
Who this helps: This helps patients struggling with both SUD and ADHD.
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
2021
Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie
Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA +50 more
Plain English This study focused on how to best screen, diagnose, and treat teenagers who have both Attention-Deficit/Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD). Experts from around the world agreed on 36 important points, including the recommendation for routine screening for ADHD in teens undergoing substance abuse treatment and the use of long-acting stimulants as the preferred medication for ADHD in these cases. This guidance aims to improve treatment outcomes for affected adolescents by ensuring they receive appropriate and effective care.
Who this helps: This helps teenagers dealing with both ADHD and substance use issues, along with their healthcare providers.
Toward High Spatially Resolved Proteomics Using Expansion Microscopy.
2021
Analytical chemistry
Drelich L, Aboulouard S, Franck J, Salzet M, Fournier I +1 more
Plain English This study looked at a new way to examine tiny structures in tissues using a technique called expansion microscopy. The researchers developed a method that expands tissue samples over three times their original size, allowing them to identify up to 655 different proteins from a small piece of tissue that is only 1 mm wide, which corresponds to about 260 cells. This is important because it makes it easier and more affordable to analyze proteins in specific areas of tissues, which can lead to better understanding of diseases.
Who this helps: This helps researchers and doctors studying diseases at the molecular level.
Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychometric properties of the Swedish Barratt impulsiveness scale.
2021
BMC psychiatry
Khemiri L, Brynte C, Konstenius M, Guterstam J, Rosendahl I +2 more
Plain English Researchers studied a questionnaire called the Swedish Barratt Impulsiveness Scale (swe-BIS) to see how well it measures impulsivity in healthy people and those with substance use disorders (like alcohol and amphetamines) and ADHD. They found that healthy individuals scored lower on the swe-BIS than patients, with significant differences between all groups. The scale showed strong reliability and validity, meaning it works well for assessing impulsivity in these populations, making it useful for clinical research.
Who this helps: This benefits patients with impulsivity issues and the doctors treating them.
Jeanette Westman Jonas Hällgren Mika Gissler Christoffer Brynte Maija Konstenius Härje Widing Romain Icick Wim van den Brink Zsolt Demetrovics Máté Kapitány-Fövény
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.